- Home
- RUN vs PTGX Comparison
RUN vs PTGX Comparison
Compare RUN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- PTGX
- Stock Information
- Founded
- RUN 2007
- PTGX 2006
- Country
- RUN United States
- PTGX United States
- Employees
- RUN N/A
- PTGX N/A
- Industry
- RUN Industrial Machinery/Components
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- RUN Miscellaneous
- PTGX Health Care
- Exchange
- RUN Nasdaq
- PTGX Nasdaq
- Market Cap
- RUN 3.7B
- PTGX 3.7B
- IPO Year
- RUN 2015
- PTGX 2016
- Fundamental
- Price
- RUN $15.79
- PTGX $61.96
- Analyst Decision
- RUN Buy
- PTGX Strong Buy
- Analyst Count
- RUN 20
- PTGX 9
- Target Price
- RUN $16.35
- PTGX $70.44
- AVG Volume (30 Days)
- RUN 10.2M
- PTGX 925.0K
- Earning Date
- RUN 11-06-2025
- PTGX 11-06-2025
- Dividend Yield
- RUN N/A
- PTGX N/A
- EPS Growth
- RUN N/A
- PTGX N/A
- EPS
- RUN N/A
- PTGX 0.80
- Revenue
- RUN $2,129,272,000.00
- PTGX $209,180,000.00
- Revenue This Year
- RUN $11.84
- PTGX N/A
- Revenue Next Year
- RUN $8.69
- PTGX $248.17
- P/E Ratio
- RUN N/A
- PTGX $73.55
- Revenue Growth
- RUN 3.27
- PTGX N/A
- 52 Week Low
- RUN $5.38
- PTGX $33.31
- 52 Week High
- RUN $21.77
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- RUN 53.83
- PTGX 61.44
- Support Level
- RUN $15.70
- PTGX $57.90
- Resistance Level
- RUN $16.97
- PTGX $60.40
- Average True Range (ATR)
- RUN 1.06
- PTGX 2.45
- MACD
- RUN -0.30
- PTGX 0.05
- Stochastic Oscillator
- RUN 21.81
- PTGX 97.65
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.